MeiraGTx Holdings PLC (FRA:328)
€ 6.1 -0.2 (-3.17%) Market Cap: 500.99 Mil Enterprise Value: 466.77 Mil PE Ratio: 0 PB Ratio: 5.50 GF Score: 47/100

MeiraGTx Holdings PLC at Barclays Gene Editing & Gene Therapy Summit (Virtual) Transcript

Nov 15, 2021 / 07:00PM GMT
Release Date Price: €17 (-0.58%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Good afternoon, everyone. My name is Gena Wang. I'm SMID cap biotech analyst at the Barclays. Welcome to our Fifth Gene Editing & Gene Therapy Summit. It is my great pleasure to introduce our next speaker, Zandy Forbes, President and Chief Executive Officer from MeiraGTx. Zandy, I'll hand over to you.

Alexandria Forbes
MeiraGTx Holdings plc - CEO, President & Director

Thank you, Gena. Thanks for inviting us to speak at your conference. And I think the format is today, I'm going to do a quick overview of the company, 5, 10 minutes. And then we're going to have questions and answers. Is that correct?

Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Yes, that's correct.

Alexandria Forbes
MeiraGTx Holdings plc - CEO, President & Director

Perfect. So for that quick summary of the company, I'm going to share a slide, just 1 slide, which sort of shows the whole company laid

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot